Susceptibility to programmed cell death in T-lymphocytes from septic patients: A mechanism for lymphopenia and Th2 predominance

Biochemical and Biophysical Research Communications

Volumn 308, Issue 4, 2003, Pages 840-846

  Roth, Georg ^a   Moser, Bernhard ^b   Krenn, Claus ^a   Brunner, Markus ^a   Haisjackl, Markus ^a   Almer, Gabriele ^a   Gerlitz, Sabine ^a   Wolner, Ernst ^a   Boltz Nitulescu, George ^a   Ankersmit, Hendrik J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; CD95; ICE; IL 10; Sepsis; TNFR1

Indexed keywords

ANTIBODY; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA CONVERTING ENZYME; PHYTOHEMAGGLUTININ; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; TH1 CELL; TH2 CELL;

EID: 0042661093     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01482-7     Document Type: Article

References (32)

1. Stone R. Search for sepsis drugs goes on despite past failures. Science. 264:1994;365-367.
2. Karima R., Matsumoto S., Higashi H., Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol. Med. Today. 5:1999;123-132.
3. Hotchkiss R.S., Swanson P.E., Cobb J.P., Jacobson A., Buchman T.G., Karl I.E. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit. Care Med. 25:1997;1298-1307.
4. Ayala A., Herdon C.D., Lehman D.L., Ayala C.A., Chaudry C.H. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood. 87:1996;4261-4275.
5. Hotchkiss R.S., Swanson P.E., Freeman B.D., Tinsley K.W., Cobb J.P., Matuschak G.M., Buchman T.G., Karl I.E. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27:1999;1230-1251.
6. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24:1996;1125-1128.
7. + T lymphocytes in humans. J. Immunol. 166:2001;6952-6963.
8. Papathanassoglou E.D., Moynihan J.A., McDermott M.P., Ackerman M.H. Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Crit. Care Med. 29:2001;709-718.
9. Hotchkiss R.S., Karl I.E. The Fas death pathway as a mechanism of multiple organ dysfunction syndrome: not so fast. Crit. Care Med. 29:2001;901-902.
10. Ankersmit H.J., Moser B., Roedler S., Teufel I., Zuckermann A., Roth G., Lietz K., Back C., Gerlitz S., Wolner E., Boltz-Nitulescu G. Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy. Clin. Exp. Immunol. 127:2002;183-189.
11. Ankersmit H.J., Tugulea S., Spanier T., Weinberg A.D., Artrip J.H., Burke E.M., Flannery M., Mancini D., Rose E.A., Edwards N.M., Oz M.C., Itescu S. Activation-induced T-cell death and immune dysfunction after implantation in left ventricular assist device. Lancet. 354:1999;550-555.
12. Ankersmit H.J., Deicher R., Moser B., Teufel I., Roth G., Gerlitz S., Itescu S., Wolner E., Boltz-Nitulescu G., Kovarik J. Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin. Exp. Immunol. 125:2001;142-148.
13. Nozawa K., Kayagaki N., Tokano Y., Yagita H., Okumura K., Hashimoto H. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum. 40:1997;1126-1129.
14. Pimentel-Muinos F.X., Seed B. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity. 11:1999;783-793.
15. Schumann R.R., Belka C., Reuter D., Lamping N., Kirschning C.J., Weber J.R., Pfeil D. Lipopolysaccaride activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood. 91:1998;577-584.
16. Vermes I., Haanen C., Reutelingsperger C. Flow cytometry of apoptotic cell death. J. Immunol. Methods. 243:2000;167-190.
17. Zunino S.J., Singh M.K., Bass J., Picker L.J. Immunodetection of histone epitopes correlates with early stages of apoptosis in activated human peripheral T lymphocytes. Am. J. Pathol. 149:1996;653-663.
18. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:1992;331-340.
19. Krammer P.H. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71:1999;163-210.
20. Ju S.T., Panka D.J., Cui H., Ettinger R., el-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444-448.
21. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1995;1545-1556.
22. Zhang D., Pasternack M.S., Beresford P.J., Wagner L., Greenberg A.H., Lieberman J. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A. J. Biol. Chem. 276:2001;3683-3690.
23. Ledru E., Lecoeur H., Garcia S., Debord T., Gougeon M.L. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J. Immunol. 160:1998;3184-3206.
24. Oberholzer A., Oberholzer C., Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syndrome and its potential as an anti-inflammatory drug. Crit. Care Med. 30(Suppl. 1):2002;S58-S63.
25. Reddy R.C., Chen G.H., Tekchandani P.K., Standiford T.J. Sepsis-induced immunosuppression: from bad to worse. Immunol. Res. 24:2001;273-287.
26. Moore K.W., O'Gaara A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
27. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:2001;683-765.
28. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:1991;915-924.
29. Oberholzer C., Oberholzer A., Clare-Salzler M., Moldawer L.L. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15:2001;879-892.
30. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104:2001;487-501.
31. Los M., Van de Craen M., Penning L.C., Schenk H., Westendorp M., Baeuerle P.A., Droge W., Krammer P.H., Fiers W., Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:1995;81-83.
32. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.